Please login to the form below
3
Revenue 2017Roche
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Sourcing R&D innovation: why pharma companies need to evolve their business models
In 2019, Qualcomm Life, Inc. and Roche agreed to a strategic collaboration to improve remote monitoring and management of chronic disease patients.
HTA guidance from NICE, the SMC and the AWMSG
Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.
Roche’s flu pill Xofluza gains EU approval
Swiss pharma company Roche has scored approval from the European Commission (EC) for its flu pill Xofluza. ... We are delighted that the European Commission has approved Xofluza, a first-in-class, single-dose oral medicine, for the treatment of influenza,
Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma
Another competitor in the SMA market – Roche’s Evrysdi (risdiplam) – was recently approved in the US for the treatment of SMA in adults and children aged two months and older, following ... Roche has priced Evrysdi by patient weight, with a maximum
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Nucleus Global announces a trio of promotions
- PHE study finds people who have had COVID-19 can still transmit the virus
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
- Janet Woodcock named acting commissioner of the FDA
- Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find
- 3 reasons why clinical trials will thrive in 2021
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- 3 reasons why clinical trials will thrive in 2021
- It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
- Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
- The pandemic preparedness paradox
- Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Quick links
Infographics
